Skip to content
healthcare.dev
Get a free key

Irinotecan Hydrochloride

NDC 25021-230, irinotecan hydrochloride, injection, solution, from Sagent Pharmaceuticals.

Product NDC
25021-230
Status
Listed
Labeler
Sagent Pharmaceuticals
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090675
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25021-230 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IRINOTECAN HYDROCHLORIDE20 mg/mL

Pharmacologic classes

Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
25021-230-02250210230021 VIAL in 1 CARTON (25021-230-02) / 2 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/caab50e6-0dad-4ddd-9a6c-96cc2b87aee7

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=25021-230

Use it

Look up 25021-230 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25021-230 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25021-230. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.